Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment ...

A study highlights an unmet need for patients with acute myeloid leukemia (AML) to access and afford genomic testing, especially among an older patient population. In a real-world setting of new and ...

Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...

Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis The classification of AML and therapeutic options are now largely driven ...

Servier India, a subsidiary of the leading French pharmaceutical company Servier Group, has introduced the patient-centric biomarker testing initiative in collaboration with MedGenome and Strand Life ...